Search research articles
Contact Us
Filters
Showing results (111-120 of 120) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 120 results.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer
G V Scagliotti, U Ricardi, L Crinó, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 6, 2000
A three-week schedule of gemcitabine-cisplatin in advanced non-small-cell lung cancer with two different cisplatin dose levels: a phase II randomized trial
M Rinaldi, L Crinò, G V Scagliotti, et al.
Breast Cancer Research and Treatment
|
October 24, 2003
Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients
V Ludovini, A Sidoni, L Pistola, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 21, 2002
Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer: a prospective randomised study
M Colozza, G Bisagni, A M Mosconi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2002
Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer
G V Scagliotti, F De Marinis, M Rinaldi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study
L Crinò, G Scagliotti, M Marangolo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 5, 2003
Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC)
F Di Costanzo, A Sobrero, S Gasperoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 1999
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project
L Crinò, G V Scagliotti, S Ricci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 18, 2010
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference
F Roila, J Herrstedt, M Aapro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1988
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial
, G Ambrosini, M Balli, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 120) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 120 results.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer
G V Scagliotti, U Ricardi, L Crinó, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 6, 2000
A three-week schedule of gemcitabine-cisplatin in advanced non-small-cell lung cancer with two different cisplatin dose levels: a phase II randomized trial
M Rinaldi, L Crinò, G V Scagliotti, et al.
Breast Cancer Research and Treatment
|
October 24, 2003
Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients
V Ludovini, A Sidoni, L Pistola, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 21, 2002
Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer: a prospective randomised study
M Colozza, G Bisagni, A M Mosconi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2002
Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer
G V Scagliotti, F De Marinis, M Rinaldi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study
L Crinò, G Scagliotti, M Marangolo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 5, 2003
Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC)
F Di Costanzo, A Sobrero, S Gasperoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 1999
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project
L Crinò, G V Scagliotti, S Ricci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 18, 2010
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference
F Roila, J Herrstedt, M Aapro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1988
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial
, G Ambrosini, M Balli, et al.
Page
of 12